Alpha Cognition Inc (ACOG.CA) Fundamental Analysis & Valuation

TSX-V:ACOG • CA02074J2048

Current stock price

0.39 CAD
-0.06 (-14.29%)
Last:

This ACOG.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ACOG.CA Profitability Analysis

1.1 Basic Checks

  • In the past year ACOG has reported negative net income.
  • In the past year ACOG has reported a negative cash flow from operations.
ACOG.CA Yearly Net Income VS EBIT VS OCF VS FCFACOG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • ACOG has a worse Return On Assets (-239.04%) than 80.65% of its industry peers.
  • ACOG has a Return On Equity (-839.02%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -239.04%
ROE -839.02%
ROIC N/A
ROA(3y)-210.28%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACOG.CA Yearly ROA, ROE, ROICACOG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 -10K -20K -30K

1.3 Margins

  • ACOG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACOG.CA Yearly Profit, Operating, Gross MarginsACOG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ACOG.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ACOG has more shares outstanding
  • ACOG has a worse debt/assets ratio than last year.
ACOG.CA Yearly Shares OutstandingACOG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M
ACOG.CA Yearly Total Debt VS Total AssetsACOG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

  • ACOG has an Altman-Z score of -17.23. This is a bad value and indicates that ACOG is not financially healthy and even has some risk of bankruptcy.
  • ACOG has a worse Altman-Z score (-17.23) than 61.29% of its industry peers.
  • A Debt/Equity ratio of 0.89 indicates that ACOG is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.89, ACOG perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -17.23
ROIC/WACCN/A
WACCN/A
ACOG.CA Yearly LT Debt VS Equity VS FCFACOG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 5M -5M

2.3 Liquidity

  • ACOG has a Current Ratio of 2.04. This indicates that ACOG is financially healthy and has no problem in meeting its short term obligations.
  • ACOG has a Current ratio (2.04) which is in line with its industry peers.
  • A Quick Ratio of 2.04 indicates that ACOG has no problem at all paying its short term obligations.
  • ACOG has a Quick ratio (2.04) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
ACOG.CA Yearly Current Assets VS Current LiabilitesACOG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ACOG.CA Growth Analysis

3.1 Past

  • ACOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.26%, which is quite good.
EPS 1Y (TTM)12.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. ACOG.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • ACOG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACOG.CA Price Earnings VS Forward Price EarningsACOG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACOG.CA Per share dataACOG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACOG.CA Dividend Analysis

5.1 Amount

  • ACOG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ACOG.CA Fundamentals: All Metrics, Ratios and Statistics

Alpha Cognition Inc

TSX-V:ACOG (10/6/2023, 7:00:00 PM)

0.39

-0.06 (-14.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength24.41
Industry Growth11.19
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.89M
Revenue(TTM)N/A
Net Income(TTM)-11.06M
Analysts76.67
Price Target3.06 (684.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 18.79
P/tB 34.18
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS0.02
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -239.04%
ROE -839.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-210.28%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z -17.23
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)29.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.59%
OCF growth 3YN/A
OCF growth 5YN/A

Alpha Cognition Inc / ACOG.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Alpha Cognition Inc?

ChartMill assigns a fundamental rating of 1 / 10 to ACOG.CA.


What is the valuation status of Alpha Cognition Inc (ACOG.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to Alpha Cognition Inc (ACOG.CA). This can be considered as Overvalued.


What is the profitability of ACOG stock?

Alpha Cognition Inc (ACOG.CA) has a profitability rating of 0 / 10.